Dynamics in Post-pandemic Global Amlodipine and Olmesartan Industry: Supply and Demand, Markets and Prices 2021-2027
Report Code: KNJ668724
Publisher: Date of Publish:
No. of Pages: 158 Category: Pharmaceuticals and Healthcare Publisher: Date of Publish:
Covid-19 has impacted the supply and demand status for many industries along the supply chain. In this report a comprehensive analysis of current global Amlodipine and Olmesartan market in terms of demand and supply environment is provided, as well as price trend currently and in the next few years. Global leading players are profiled with their revenue, market share, profit margin, major product portfolio and SWOT analysis. From industry perspective this report analyses supply chain, including process chart introduction, upstream key raw material and cost analysis, distributor and downstream buyer analysis. This report also includes global and regional market size and forecast, major product development trend and typical downstream segment scenario, under the context of market drivers and inhibitors analysis. According to this survey, the global Amlodipine and Olmesartan market is estimated to have reached $ xx million in 2020, and projected to grow at a CAGR of xx% to $ xx million in 2027. Segmented by Category 5/20 mg Tablets 10/20 mg Tablets 5/40 mg Tablets 10/40 mg Tablets Segmented by End User/Segment Hospital Drug store Segmented by Country North America United States Canada Mexico Europe Germany France UK Italy Russia Spain Asia Pacific China Japan Korea Southeast Asia India Australasia Central & South America Brazil Argentina Colombia Middle East & Africa Iran Israel Turkey South Africa Saudi Arabia Key manufacturers included in this survey Torrent Pharmaceuticals Teva Matrix Laboratories Macleods Pharmaceuticals Jubilant Pharma Glenmark Pharmaceuticals Daiichi Sankyo Aurobindo Alembic Pharmaceuticals Ajanta Pharma Accord Healthcare
Table of Contents 1 Product Introduction and Overview 1.1 Product Definition 1.2 Product Specification 1.3 Global Market Overview 1.3.1 Global Amlodipine and Olmesartan Market Status and Forecast (2016-2027) 1.3.2 Global Amlodipine and Olmesartan Sales Value CAGR by Region 1.4 Market Drivers, Inhibitors 1.4.1 Market Drivers 1.4.2 Market Inhibitors 1.4.3 COVID-19 Impact Analysis 2 Global Amlodipine and Olmesartan Supply by Company 2.1 Global Amlodipine and Olmesartan Sales Volume by Company 2.2 Global Amlodipine and Olmesartan Sales Value by Company 2.3 Global Amlodipine and Olmesartan Price by Company 2.4 Amlodipine and Olmesartan Production Location and Sales Area of Main Manufacturers 2.5 Trend of Concentration Rate 3 Global and Regional Amlodipine and Olmesartan Market Status by Category 3.1 Amlodipine and Olmesartan Category Introduction 3.1.1 5/20 mg Tablets 3.1.2 10/20 mg Tablets 3.1.3 5/40 mg Tablets 3.1.4 10/40 mg Tablets 3.2 Global Amlodipine and Olmesartan Market by Category 3.2.1 Global Amlodipine and Olmesartan Sales Volume by Category (2016-2021) 3.2.2 Global Amlodipine and Olmesartan Sales Value by Category (2016-2021) 3.2.3 Global Amlodipine and Olmesartan Price by Category (2016-2021) 3.3 North America: by Category 3.4 Europe: by Category 3.5 Asia Pacific: by Category 3.6 Central & South America: by Category 3.7 Middle East & Africa: by Category 4 Global and Regional Amlodipine and Olmesartan Market Status by End User/Segment 4.1 Amlodipine and Olmesartan Segment by End User/Segment 4.1.1 Hospital 4.1.2 Drug store 4.2 Global Amlodipine and Olmesartan Market by End User/Segment 4.2.1 Global Amlodipine and Olmesartan Sales Volume by End User/Segment (2016-2021) 4.2.2 Global Amlodipine and Olmesartan Sales Value by End User/Segment (2016-2021) 4.2.3 Global Amlodipine and Olmesartan Price by End User/Segment (2016-2021) 4.3 North America: by End User/Segment 4.4 Europe: by End User/Segment 4.5 Asia Pacific: by End User/Segment 4.6 Central & South America: by End User/Segment 4.7 Middle East & Africa: by End User/Segment 5 Global Amlodipine and Olmesartan Market Status by Region 5.1 Global Amlodipine and Olmesartan Market by Region 5.1.1 Global Amlodipine and Olmesartan Sales Volume by Region 5.1.2 Global Amlodipine and Olmesartan Sales Value by Region 5.2 North America Amlodipine and Olmesartan Market Status 5.3 Europe Amlodipine and Olmesartan Market Status 5.4 Asia Pacific Amlodipine and Olmesartan Market Status 5.5 Central & South America Amlodipine and Olmesartan Market Status 5.6 Middle East & Africa Amlodipine and Olmesartan Market Status 6 North America Amlodipine and Olmesartan Market Status 6.1 North America Amlodipine and Olmesartan Market by Country 6.1.1 North America Amlodipine and Olmesartan Sales Volume by Country (2016-2021) 6.1.2 North America Amlodipine and Olmesartan Sales Value by Country (2016-2021) 6.2 United States 6.3 Canada 6.4 Mexico 7 Europe Amlodipine and Olmesartan Market Status 7.1 Europe Amlodipine and Olmesartan Market by Country 7.1.1 Europe Amlodipine and Olmesartan Sales Volume by Country (2016-2021) 7.1.2 Europe Amlodipine and Olmesartan Sales Value by Country (2016-2021) 7.2 Germany 7.3 France 7.4 UK 7.5 Italy 7.6 Russia 7.7 Spain 8 Asia Pacific Amlodipine and Olmesartan Market Status 8.1 Asia Pacific Amlodipine and Olmesartan Market by Country 8.1.1 Asia Pacific Amlodipine and Olmesartan Sales Volume by Country (2016-2021) 8.1.2 Asia Pacific Amlodipine and Olmesartan Sales Value by Country (2016-2021) 8.2 China 8.3 Japan 8.4 Korea 8.5 Southeast Asia 8.6 India 8.7 Australasia 9 Central & South America Amlodipine and Olmesartan Market Status 9.1 Central & South America Amlodipine and Olmesartan Market by Country 9.1.1 Central & South America Amlodipine and Olmesartan Sales Volume by Country (2016-2021) 9.1.2 Central & South America Amlodipine and Olmesartan Sales Value by Country (2016-2021) 9.2 Brazil 9.3 Argentina 9.4 Colombia 10 Middle East & Africa Amlodipine and Olmesartan Market Status 10.1 Middle East & Africa Amlodipine and Olmesartan Market by Country 10.1.1 Middle East & Africa Amlodipine and Olmesartan Sales Volume by Country (2016-2021) 10.1.2 Middle East & Africa Amlodipine and Olmesartan Sales Value by Country (2016-2021) 10.2 Iran 10.3 Israel 10.4 Turkey 10.5 South Africa 10.8 Saudi Arabia 11 Supply Chain and Manufacturing Cost Analysis 11.1 Supply Chain Analysis 11.2 Production Process Chart Analysis 11.3 Raw Materials and Key Suppliers Analysis 11.3.1 Raw Materials Introduction 11.3.2 Raw Materials Key Suppliers List 11.4 Amlodipine and Olmesartan Manufacturing Cost Analysis 11.5 Amlodipine and Olmesartan Sales Channel and Distributors Analysis 11.5.1 Amlodipine and Olmesartan Sales Channel 11.5.2 Amlodipine and Olmesartan Distributors 11.6 Amlodipine and Olmesartan Downstream Major Buyers 12 Global Amlodipine and Olmesartan Market Forecast by Category and by End User/Segment 12.1 Global Amlodipine and Olmesartan Sales Volume and Sales Value Forecast (2022-2027) 12.2 Global Amlodipine and Olmesartan Forecast by Category 12.2.1 Global Amlodipine and Olmesartan Sales Volume Forecast by Category 12.2.2 Global Amlodipine and Olmesartan Sales Value Forecast by Category 12.2.3 Global Amlodipine and Olmesartan Price Forecast by Category 12.3 Global Amlodipine and Olmesartan Forecast by End User/Segment 12.3.1 Global Amlodipine and Olmesartan Sales Volume Forecast by End User/Segment 12.3.2 Global Amlodipine and Olmesartan Sales Value Forecast by End User/Segment 12.3.3 Global Amlodipine and Olmesartan Price Forecast by End User/Segment 13 Global Amlodipine and Olmesartan Market Forecast by Region/Country 13.1 Global Amlodipine and Olmesartan Market Forecast by Region (2022-2027) 13.1.1 Global Amlodipine and Olmesartan Sales Volume Forecast by Region (2022-2027) 13.1.2 Global Amlodipine and Olmesartan Sales Value Forecast by Region (2022-2027) 13.2 North America Market Forecast 13.3 Europe Market Forecast 13.4 Asia Pacific Market Forecast 13.5 Central & South America Market Forecast 13.6 Middle East & Africa Market Forecast 14 Key Participants Company Information 14.1 Torrent Pharmaceuticals 14.1.1 Company Information 14.1.2 Amlodipine and Olmesartan Product Introduction 14.1.3 Torrent Pharmaceuticals Amlodipine and Olmesartan Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.1.4 SWOT Analysis 14.2 Teva 14.2.1 Company Information 14.2.2 Amlodipine and Olmesartan Product Introduction 14.2.3 Teva Amlodipine and Olmesartan Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.2.4 SWOT Analysis 14.3 Matrix Laboratories 14.3.1 Company Information 14.3.2 Amlodipine and Olmesartan Product Introduction 14.3.3 Matrix Laboratories Amlodipine and Olmesartan Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.3.4 SWOT Analysis 14.4 Macleods Pharmaceuticals 14.4.1 Company Information 14.4.2 Amlodipine and Olmesartan Product Introduction 14.4.3 Macleods Pharmaceuticals Amlodipine and Olmesartan Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.4.4 SWOT Analysis 14.5 Jubilant Pharma 14.5.1 Company Information 14.5.2 Amlodipine and Olmesartan Product Introduction 14.5.3 Jubilant Pharma Amlodipine and Olmesartan Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.5.4 SWOT Analysis 14.6 Glenmark Pharmaceuticals 14.6.1 Company Information 14.6.2 Amlodipine and Olmesartan Product Introduction 14.6.3 Glenmark Pharmaceuticals Amlodipine and Olmesartan Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.6.4 SWOT Analysis 14.7 Daiichi Sankyo 14.7.1 Company Information 14.7.2 Amlodipine and Olmesartan Product Introduction 14.7.3 Daiichi Sankyo Amlodipine and Olmesartan Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.7.4 SWOT Analysis 14.8 Aurobindo 14.8.1 Company Information 14.8.2 Amlodipine and Olmesartan Product Introduction 14.8.3 Aurobindo Amlodipine and Olmesartan Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.8.4 SWOT Analysis 14.9 Alembic Pharmaceuticals 14.9.1 Company Information 14.9.2 Amlodipine and Olmesartan Product Introduction 14.9.3 Alembic Pharmaceuticals Amlodipine and Olmesartan Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.9.4 SWOT Analysis 14.10 Ajanta Pharma 14.10.1 Company Information 14.10.2 Amlodipine and Olmesartan Product Introduction 14.10.3 Ajanta Pharma Amlodipine and Olmesartan Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.10.4 SWOT Analysis 14.11 Accord Healthcare 15 Conclusion 16 Methodology
NEED Help?
If you need any help or guidance, please feel free to call us.
USA : +1 (661) 636 6162
INDIA : +91 9325802062
or
Write us on : sales@kandjmarketresearch.com